Piramal Enterprises informs about acquisition

23 Jun 2021 Evaluate

The company had, through its letter dated 31st March, 2021, made a disclosure regarding the acquisition of 100% stake in Hemmo Pharmaceuticals (‘Hemmo’), for an aggregate cash consideration of Rs 775 crores and earn-outs linked to achievement of milestones, by Piramal Pharma (‘PPL’), subsidiary of the Company (‘Transaction’). Piramal Enterprises has informed that PPL has completed the acquisition of Hemmo on 22nd June, 2021 and the Transaction is now closed.

The above information is a part of company’s filings submitted to BSE.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 927.85
Shriram Finance 1003.45
Aditya Birla Capital 347.85
Chola Invest & Fin. 1642.60
Tata Capital 352.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×